Aevi Genomic Medicine Inc (NASDAQ:GNMX)

2.24
Delayed Data
As of Feb 16
 +0.01 / +0.45%
Today’s Change
0.98
Today|||52-Week Range
6.18
+86.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$132.9M

Company Description

Aevi Genomic Medicine, Inc. is a medical technology company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts include an ongoing collaboration a pediatric academic medical center. The company was founded on January 27, 2000 and is headquartered in Wayne, PA.

Contact Information

Aevi Genomic Medicine, Inc.
435 Devon Park Drive
Wayne Pennsylvania 19087
P:(610) 254-4201
Investor Relations:

Employees

Shareholders

Other institutional18.86%
Individual stakeholders12.69%
Mutual fund holders1.70%

Top Executives

Michael F. ColaPresident, Chief Executive Officer & Director
Brian D. PiperChief Financial & Accounting Officer, Secretary
Garry Arthur NeilChief Scientific Officer